 |
 |
 |
 |
Bookmark Health Information
Make Health Information Your Homepage
|
 |
|
Herbal Medicine
PAKISTANI EPHEDRA (Ephedra gerardiana Wall. ex Stapf) +
Activities (Pakistani Ephedra) : Alterative (f; CRC); Analeptic (1; WOI); Anesthetic (1; WOI); Antipyretic (f; KAB); Astringent (f; CRC; KAB); Bronchodilator (1; WOI); Cardiodepressant (f; CRC); Cardiotonic (f; KAB); CNS Stimulant (1; CRC; WOI); Decongestant (1; WOI); Diaphoretic (f; CRC; KAB); Diuretic (f; CRC); Mydriatic (f; CRC); Myodepressant (f; CRC); Respirastimulant (1; WOI); Stomachic (f; CRC); Tonic (f; CRC); Uterocontractant (1; WOI); Vasoconstrictor (1; WOI).
Indications (Pakistani Ephedra) : Allergy (f; CRC); Asthma (1; CRC; KAB; SKJ); Bronchosis (f; SKJ); Cold (f; CRC); Congestion (1; WOI); Coryza (f; WOI); Cough (f; CRC); Depression (1; WOI); Dermatosis (f; CRC); Diarrhea (f; CRC); Diphtheria (f; KAB); Edema (f; CRC); Emphysema (1; CRC); Enuresis (f; CRC; SKJ); Epilepsy (f; CRC); Eruption (f; CRC); Exophthalmia (f; CRC); Fever (f; CRC; KAB); Goiter (f; CRC); Hay Fever (1; CRC; SKJ; WOI); Headache (f; CRC); Heart (f; KAB); Hyperemia (1; CRC); Hypotension (f; CRC); Itch (f; CRC); Malaria (f; CRC); Mucososis (f; WOI); Myasthenia gravis (f; CRC); Narcolepsy (1; WOI); Pain (1; WOI); Pertussis (f; CRC); Pneumonia (f; KAB); Rash (f; SKJ); Respirosis (f; KAB); Rheumatism (f; CRC); Rhinosis (1; CRC; WOI); Sinusosis (f; SKJ; WOI); Syphilis (f; KAB); Urticaria (f; CRC); VD (f; CRC).
Contraindications, Interactions, and Side Effects (Pakistani Ephedra) : Classified by the FDA as an Herb of Undefined Safety. Used as an antisyphilitic. Also used as an astringent. A Chinese species, Ephedra sinica, called ma-huang in China, contains the alkaloid ephedrine, a powerful decongestant. In large doses, ephedrine causes headache, indigestion, nervousness, flushing, numbing of the extremities, nausea, tingling, palpitations, and vertigo. Contact dermatosis may occur at onset of application or as much as 2 years later. (CRC).
Hit: 363
Print
Health Information Homepage
| |
|
 |
 |
 |
 |